Skip to main content

Nektar Therapeutics 10-Q for FY2024 Q2

Nektar Therapeutics (NKTR)

10-Q 2024-08-09 For: 2024-06-30
View Original
Added on April 04, 2026

About this 10-Q

Nektar Therapeutics filed this 10-Q on August 9, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$23.49M
up 14.6% from $20.5M a year earlier
Net loss
$52.36M
compared with a net loss of $51.12M a year earlier
Diluted EPS
-$0.25
compared with -$0.27 a year earlier